Cargando…

SUN-386 Treatment Outcomes of Intravenous Zoledronic Acid vs Oral Alendronate in Postmenopausal Women with Osteoporosis

In real practice, many patients with osteoporosis are poorly compliant with oral bisphosphonate, partly due to gastrointestinal side effects and partly due to medication procedure leading to premature termination of treatment. Once yearly intravenous zoledronic acid is well tolerated; little or no g...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pyone, Zar Chi, Aung, Moe Wint, Myint, Thein, Khin, Than Saw, Hlaing, Thinn Thinn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Bone and Mineral Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208430/ http://dx.doi.org/10.1210/jendso/bvaa046.850

Ejemplares similares

MON-378 Efficacy and Safety of Romosozumab vs Alendronate Is Similar Across Different Levels of Renal Function Among Postmenopausal Women with Osteoporosis
por: Miller, Paul, et al.
Publicado: (2020)

SUN-389 Trends in Osteoporosis Treatment Uptake and Persistence Among Postmenopausal Women in the U.S., 2010–2015
por: Kim, Min, et al.
Publicado: (2020)

SUN-LB65 Circulating Micrornas Linked to Bone Metabolism Are Affected by Sequential Anti Osteoporotic Treatment in Postmenopausal Osteoporosis
por: Yavropoulou, Maria, et al.
Publicado: (2020)

MON-386 Determining Vitamin D Status: Analytical Variability Between Available Assays
por: Wahab, Azni Lihawa Abdul, et al.
Publicado: (2020)

OR01-5 Transition From Low Dose Denosumab 30mg to IV Zoledronic Acid: Effect on Bone Mineral Density in Postmenopausal Women with Osteoporosis: A Prospective Observational Study
por: Ibrahim, Quazi, et al.
Publicado: (2022)

SUN-377 Efficacy of Low Dose Denosumab in Maintaining Bone Mineral Density in Postmenopausal Women with Osteoporosis: A Real World, Prospective Observational Study
por: Khan, Aliya Aziz, et al.
Publicado: (2020)

SUN-395 Pelvic Bone Density Is Lower Than Bone Density of Hip and Femoral Neck in Postmenopausal Women
por: Mohseni, Mahshid, et al.
Publicado: (2020)

ODP131 Zoledronic acid and red eye
por: Patel, Urja, et al.
Publicado: (2022)

SUN-391 Denosumab Treatment of Patients with Osteoporosis and Idiopathic Hypercalciuria
por: Chu, Winston S, et al.
Publicado: (2020)

SAT-386 Inconsistent Bilateral Arm Serum PTH Testing in Recurrent Hyperparathyroidism in a Patient Status-Post Parathyroid Auto-Transplantation
por: Jenkins, Craig, et al.
Publicado: (2020)

THU442 A Case Of Early Medication Related Osteonecrosis Of The Jaw In Patient Receiving Intravenous Zoledronate For Treatment Of Osteoporosis
por: Ekpe, Victor, et al.
Publicado: (2023)

SUN-538 Osteogenic Markers in Postmenopausal Diabetics Respond to Higher Mechanical Loading during Exercise after Rather Than before the Meals
por: Borer, Katarina, et al.
Publicado: (2019)

THU443 Acute Iridocyclitis Associated With Intravenous Zoledronic Acid
por: Ankireddypalli, Anvitha Reddy, et al.
Publicado: (2023)

THU446 A Case Of Isolated Osteonecrosis Of Torus Palatinus In A Patient On Alendronate
por: Noor, Abdullah Awsaf, et al.
Publicado: (2023)

SAT-LB092 Adherence to Weekly Alendronate Predicts Mortality in Male US Military Veterans
por: Puri, Ritika, et al.
Publicado: (2019)

MON-LB71 Adult Hypophosphatasia and Postmenopausal Osteoporosis: A Challenging Case
por: Abramof-Ness, Rosane, et al.
Publicado: (2020)

Severe Hypophosphatemia and Elevated FGF23 Level Following Zoledronic Acid Infusion
por: Betlachin, Anna, et al.
Publicado: (2021)

THU426 Randomized Controlled Trial Comparing The Efficacy Of Teriparatide, Zoledronate And Denosumab In Postmenopausal Women With Type 2 Diabetes Mellitus At High Risk Of Fragility Fractures: 6-month Interim Analysis Of HR-pQCT Parameters
por: Pal, Rimesh, et al.
Publicado: (2023)

SUN-512 Denosumab Improves Trabecular but Not Cortical Bone Osteoporosis in a Patient with Refractory Primary Hyperparathyroidism
por: Alhassan, Sharifa, et al.
Publicado: (2019)

ODP107 Oral Ulcerations, A Rare Side Effect of Intravenous Zoledronic Acid
por: Del Mar Morales Hernandez, Maria, et al.
Publicado: (2022)

THU449 An Unexpected Case Of Cutaneous Leukocytoclastic Vasculitis Following Zoledronic Acid Infusion
por: Zahedi, Bita, et al.
Publicado: (2023)

OR13-02 Treatment with Zoledronic Acid Subsequent to Denosumab Cannot Fully Prevent Bone Loss
por: Sølling, Anne Sophie K, et al.
Publicado: (2020)

THU444 A Case Of Zoledronic-Acid Induced Acute Anterior Uveitis, Episcleritis, And Synovitis
por: Au, Xiu Ying, et al.
Publicado: (2023)

SUN-374 Decisions to Accept or Decline Pharmacologic Osteoporosis Therapy After Attending a Novel Patient-Centred Educonsult Program for Osteoporosis (PEP-OP)
por: Liu, Crystal Sixian, et al.
Publicado: (2020)

OR03-1 The Effect of Abaloparatide on Bone Mineral Density and Fracture Incidence in Postmenopausal Women with Osteoporosis and Osteoarthritis
por: Lane, Nancy, et al.
Publicado: (2019)

SUN-380 Opportunistic Screening with Abdominal CT in Patients with Diabetes Can Identify Those at High Risk of Osteoporosis and Osteopenia
por: Jain, Rajesh, et al.
Publicado: (2020)

SUN-490 Enigmatic Presentations Of Hyperparathyroidism
por: NAGAPRIYA, VELLALACHERUVU, et al.
Publicado: (2019)

SUN-505 The Invincible Parathyroid Gland
por: Mayorga, Mabel, et al.
Publicado: (2019)

SAT-539 The Utility of Prophylactic Zoledronic Acid in Patients Undergoing Lung Transplantation: A Retrospective Analysis
por: Ng, Elisabeth, et al.
Publicado: (2019)

RF30 | PSAT172 Effects of 12 Months of Alendronate Therapy Subsequent to 12 Months of Denosumab Administration in Women With Anorexia Nervosa
por: Haines, Melanie, et al.
Publicado: (2022)

SAT262 Bilateral Stress Fractures Of The Femur In A Patient With HIV On Long-term Tenofovir Disoproxil Fumarate And Short-term Alendronate
por: Mahatme, Ronak J, et al.
Publicado: (2023)

ODP130 Zoledronate-Induced Acute Tubular Necrosis With Baseline Normal Renal Function: A Rare Phenomenon
por: Khawaja, Umar Sharif, et al.
Publicado: (2022)

SUN-502 From Pseudohypoparathyroidism to Signaling Disorder
por: Imam, Ahmad, et al.
Publicado: (2019)

SUN-491 An Uncommon Presentation of Primary Hiperparathyroidism
por: Bastos, Filipa, et al.
Publicado: (2019)

ODP119 Raloxifene use after denosumab discontinuation partially attenuates bone loss in the lumbar spine in postmenopausal osteoporosis
por: Hone, Namki, et al.
Publicado: (2022)

SUN-397 The Osteosee System Measurements, Based on Parametric Electrical Impedance Tomography, Correlate with Dual X-Ray Absorptiometry Results for the Diagnosis of Osteoporosis
por: Rouach, Vanessa, et al.
Publicado: (2020)

SUN-526 Prevalence of Hyperparathyroidism in X-Linked Hypophosphatemia
por: DeLacey, Sean, et al.
Publicado: (2019)

SUN-LB67 Revisit Serum Calcium Correction
por: Li, Yulong, et al.
Publicado: (2020)

SUN-349 Characterizing Functional Performance in Adults with Hypophosphatasia
por: Dahir, Kathryn, et al.
Publicado: (2020)

SUN-376 A Quality Improvement Project on Identification and Management of Primary Hyperparathyroidism in Patients Who Present with Osteoporosis to Reduce Morbidity from Bone Disease
por: Hatta, Sharifah Faradila Wan Muhamad, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_05qs58ggcqqiq81n050s1mbr3j